This HTML5 document contains 119 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n9	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
n10	http://dx.doi.org/10.1002/
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q47784405

rdf:type

wikibase:Item

schema:description

სამეცნიერო სტატია vědecký článek научна статия บทความทางวิทยาศาสตร์ wissenschaftlicher Artikel 2004年学术文章 artigo científico bilimsel makale vedecký článok مقالة علمية نشرت في أبريل 2004 2004年學術文章 article scientific 2004 nî lūn-bûn vitskapeleg artikkel мақолаи илмӣ teaduslik artikkel tieteellinen artikkeli 2004年学术文章 научни чланак articolo scientifico artikel ilmiah 2004年學術文章 artikull shkencor wetenschappelijk artikel наукова стаття, опублікована у квітні 2004 2004年學術文章 vitenskapelig artikkel научная статья artykuł naukowy scientific article published in April 2004 artigo científico 2004年学术文章 2004年の論文 এপ্রিল ২০০৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научни чланак naučni članak 2004年学术文章 bài báo khoa học artikulong pang-agham articol științific 2004年学术文章 article scientifique videnskabelig artikel 2004年學術文章 מאמר מדעי scientific article published in April 2004 2004年學術文章 tudományos cikk artigo científico vetenskaplig artikel 2004年学术文章 artículu científicu artículo científico publicado en 2004 επιστημονικό άρθρο scientific article published in April 2004 2004년 논문 article científic scienca artikolo

p:P577

wds:Q47784405-6F0EB66E-80F4-47E2-B495-16FDEDC21917

wdt:P577

2004-04-01T00:00:00Z

p:P2860

wds:Q47784405-FBAA4FDA-FC1E-424E-9040-70E307D9A8D3

wdt:P2860

wd:Q40613837

p:P2093

wds:Q47784405-32FCFBBE-9E4C-4A05-8383-F3399CEC8103 wds:Q47784405-338907D4-88AD-4C23-B182-23C2A6040BF9 wds:Q47784405-68FDBB1C-7DE9-47CA-86F5-963BBBC32343 wds:Q47784405-57560867-E9E2-40DF-8E38-CF8354F7A859 wds:Q47784405-0774340D-DF9C-4D7E-A0FC-D66C834DA43F wds:Q47784405-F7A484A7-C1B0-4D22-B9FC-53A25BE5A070 wds:Q47784405-95590B3B-3500-441A-83FB-2377081DAEE4 wds:Q47784405-B1A67D2D-12BF-4269-AE4A-34157084A536 wds:Q47784405-C6F1FC8A-724D-47CE-BBAD-C2402DC7FCED wds:Q47784405-CE49057A-56F3-4DC6-B0BA-1E94670D5B81 wds:Q47784405-BC829EEE-3047-436B-96DF-B5D90D779C2D

wdt:P2093

P E Lipsky J S Smolen G F Keenan J R Kalden D Furst M H Weisman Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group F C Breedveld P A Marsters D van der Heijde R N Maini

rdfs:label

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.

skos:prefLabel

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.

schema:name

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.

p:P50

wds:Q47784405-6384C6E9-AE37-4C93-B3FA-4242F5A0B6B0

wdt:P50

wd:Q111610931

p:P1476

wds:Q47784405-39AEDAEC-D3F3-4DFA-A108-C101491CD78F

wdt:P1476

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.

p:P304

wds:Q47784405-E96DA633-614A-40D8-99CA-50F7FDB5E17E

wdt:P304

1051-1065

p:P31

wds:Q47784405-1922CCE7-65C3-4E18-B2E6-8F3FCB1C3305

wdt:P31

wd:Q13442814

p:P921

wds:Q47784405-DAA3B132-9A45-4030-A28F-3F05C6615C84 wds:Q47784405-DD0C4000-A7E2-4345-BB35-78CE7C6BC193 wds:Q47784405-5ED47619-E4E4-4BCF-923E-0C8D291403A3

wdt:P921

wd:Q422232 wd:Q187255 wd:Q181600

p:P698

wds:Q47784405-0C36C669-5202-4A82-A9F4-9C9902FDA136

wdtn:P698

n9:15077287

wdt:P698

15077287

p:P1433

wds:Q47784405-E0576A8E-637E-4C21-B84A-DA2B4ACD553C

wdt:P1433

wd:Q4797636

p:P433

wds:Q47784405-BCDA8840-4C77-4FC3-AC06-58C23DF7FA00

p:P478

wds:Q47784405-3EA8731C-5A8A-43D4-A8EA-33F6E411E9F5

wdt:P433

4

wdt:P478

50

p:P356

wds:Q47784405-E9ACD8B5-2809-4811-8B0E-EA0A8775681F

wdtn:P356

n10:ART.20159

wdt:P356

10.1002/ART.20159

p:P5875

wds:Q47784405-93980BF2-0C85-4765-A21A-4DD27C30B5BC

wdt:P5875

8625652